V S N Murty Kadiyala

Title: V S N Murty Kadiyala: Innovator in Malic Enzyme Inhibitors

Introduction

V S N Murty Kadiyala, an accomplished inventor based in Vadodara, India, holds a patent for innovative compounds that serve as malic enzyme inhibitors. His work is particularly critical given its implications in treating disorders mediated by malic enzyme, such as pancreatic ductal adenocarcinoma (PDAC).

Latest Patents

Kadiyala's patent addresses the development of novel compounds that function as inhibitors of malic enzyme (ME). The patent specifies the compounds' structures according to Formula I or their pharmaceutically acceptable salts, stereoisomers, or deuterated analogs. These compounds are geared toward therapeutic intervention in cancers, showcasing Kadiyala's contribution to the field of medicinal chemistry.

Career Highlights

Currently, Kadiyala is associated with Sun Pharma Advanced Research Company Limited, a leader in pharmaceutical research and development. His commitment to innovation has led to significant advancements in the understanding and application of malic enzyme inhibitors in cancer treatment.

Collaborations

Throughout his career, Kadiyala has worked alongside notable colleagues including Gaurav Sanjivkumar Sheth and Sabbirhusen Yusufbhai Chimanwala. These collaborations have fostered a dynamic research environment, further enhancing the development of new therapeutic options.

Conclusion

V S N Murty Kadiyala exemplifies the spirit of innovation in the field of medicinal therapies. His pioneering work on malic enzyme inhibitors not only contributes to the scientific community but also holds promise for enhancing treatment strategies for severe medical conditions.